Apollomics Stock (NASDAQ: APLM) stock price, news, charts, stock research, profile.
Open | $0.283 |
Close | - |
Volume / Avg. | 562.394K / 183.298K |
Day Range | 0.250 - 0.295 |
52 Wk Range | 0.280 - 6.450 |
Market Cap | $27.466M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 17 |
Short Interest | 0.16% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Apollomics (NASDAQ: APLM) through any online brokerage.
Other companies in Apollomics’s space includes: Vincerx Pharma (NASDAQ:VINC), Lumos Pharma (NASDAQ:LUMO), Evaxion Biotech (NASDAQ:EVAX), Nanoviricides (AMEX:NNVC) and Bolt Biotherapeutics (NASDAQ:BOLT).
The latest price target for Apollomics (NASDAQ: APLM) was reported by HC Wainwright & Co. on Wednesday, May 8, 2024. The analyst firm set a price target for 2.00 expecting APLM to rise to within 12 months (a possible 551.68% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Apollomics (NASDAQ: APLM) is $0.3069 last updated Today at May 23, 2024 at 9:29 AM EDT.
There are no upcoming dividends for Apollomics.
Apollomics’s H1 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Apollomics.
Apollomics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.